Pleural Infection
20
3
4
10
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 20 trials
100.0%
+13.5% vs benchmark
5%
1 trials in Phase 3/4
10%
1 of 10 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.5%
Based on 10 completed trials
Clinical Trials (20)
Role of Medical Thoracoscopy in Pleural Infection (PROMPT Trial)
Pleural Space Saline Irrigation in Addition to Standard Intrapleural Thrombolytic Therapy in Empyema/Complicated Parapneumonic Effusion
Intrapleural Alteplase-Tyloxapol vs Intrapleural Alteplase-DNase in Pleural Infection
Pleural Irrigation With Normal Saline Versus Intrapleural Fibrinolytic
Chest Drain Regular Flushing in Complicated Parapneumonic Effusions and Empyemas
Trial of Reduced Alteplase Dose for Parapneumonic Effusion (TRAPPE)
Pharmacokinetics and Pleural Fluid Penetration of Amoxicillin and Clavulanic Acid in Patients With Pleural Infections
Pleural Fluid Neutrophil Extracellular Traps Exacerbate Disease Severity and Risk of One-year Mortality in Pleural Infection (TORPIDS-3)
Diagnostic Utility of Pleural Infection-specific Multiplex PCR Panel
Fluid Agitation Microbiologic Yield In Pleural Infection Feasibility Study
The Oxford Pleural Infection Endotyping Study
Predictors of Outcome in Patients With Pleural Infection at Sohag University Hospital
Prospective Data Collection on Clinical, Radiological and Patient Reported Outcomes After Pleural Intervention
Antiseptic Irrigation for Pleural Infection
Short Versus Long Antibiotic Course for Pleural Infection Management (SLIM Trial)
Fibrinolysis Compared to Thoracoscopy for Pleural Infection
The Microbiology of Pleural Infection
Oral Versus Intravenous Antibiotics for the Treatment of Pleural Space Infection: a Randomized Controlled Pilot Trial
Fibrinolysis Compared to Thoracoscopy for Pleural Infection
Advanced Ultrasound in Pleural Infection